Literature DB >> 15255244

Blood transfusion and increased risk for vasospasm and poor outcome after subarachnoid hemorrhage.

Michelle J Smith1, Peter D Le Roux, J Paul Elliott, H Richard Winn.   

Abstract

OBJECT: Nitric oxide (NO) metabolism may influence vasospasm after subarachnoid hemorrhage (SAH). It has been demonstrated in recent studies that erythrocytes carry NO for release in vessels, whereas transfused erythrocytes may lack stored NO. Several converging lines of evidence also indicate that blood transfusion may exacerbate poor outcomes in some critically ill patients. In this study the authors hypothesized that patients with SAH who received red blood cell (RBC) transfusions were at greater risk for vasospasm and poor outcome.
METHODS: The authors retrospectively reviewed a prospective observational database, including hospital records, computerized tomography (CT) scans, and pre- and postoperative four-vessel angiograms, in which the management methods used in 441 patients undergoing surgery for ruptured cerebral aneurysms were described. Two hundred seventy patients (61.2%) received an RBC transfusion during their hospital stay. After adjustment for Hunt and Hess grade, SAH grade on CT scans, delay between rupture and surgery, smoking status, and intraoperative aneurysm rupture, a worse outcome was more likely in patients who received intraoperative blood (odds ratio [OR] 2.44, confidence interval [CI] 1.32-4.52; 120 patients). Intraoperative RBC transfusion did not influence subsequent angiographically confirmed vasospasm (OR 0.92, CI 0.6-1.4). Worse outcome was observed in patients who received blood postoperatively (OR 1.81, CI 1.21-2.7), but not after adjustments were made for confounding variables (OR 1.48, CI 0.83-2.63). Angiographic vasospasm was observed in 217 patients and, after adjusting for confounding variables, was more frequent among patients who received postoperative RBC transfusion (OR 1.68, CI 1.02-2.75). Among patients in whom angiographically confirmed vasospasm developed there was a tendency to have received more blood than in those with no vasospasm; however, a clear dose-dependent response was not observed.
CONCLUSIONS: Development of angiographically confirmed vasospasm after SAH is associated with postoperative RBC transfusion and worse outcome is associated with intraoperative RBC transfusion. Before blood is transfused, patients with SAH should be carefully assessed to determine if they are symptomatic because of anemia.

Entities:  

Mesh:

Year:  2004        PMID: 15255244     DOI: 10.3171/jns.2004.101.1.0001

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  41 in total

1.  Intraventricular nicardipine for aneurysmal subarachnoid hemorrhage related vasospasm: assessment of 90 days outcome.

Authors:  Na Lu; Daniel Jackson; Sothear Luke; Emir Festic; Ricardo A Hanel; William David Freeman
Journal:  Neurocrit Care       Date:  2012-06       Impact factor: 3.210

2.  Effects of storage-aged red blood cell transfusions on endothelial function in hospitalized patients.

Authors:  Robert Neuman; Salim Hayek; Ayaz Rahman; Joseph C Poole; Vivek Menon; Salman Sher; James L Newman; Sulaiman Karatela; David Polhemus; David J Lefer; Christine De Staercke; Craig Hooper; Arshed A Quyyumi; John D Roback
Journal:  Transfusion       Date:  2014-11-13       Impact factor: 3.157

3.  The risks of blood transfusion in patients with subarachnoid hemorrhage.

Authors:  Paul E Marik
Journal:  Neurocrit Care       Date:  2012-04       Impact factor: 3.210

4.  SANGUINATE™ (PEGylated Carboxyhemoglobin Bovine) Improves Cerebral Blood Flow to Vulnerable Brain Regions at Risk of Delayed Cerebral Ischemia After Subarachnoid Hemorrhage.

Authors:  Rajat Dhar; Hemant Misra; Michael N Diringer
Journal:  Neurocrit Care       Date:  2017-12       Impact factor: 3.210

5.  Insufficient nitric oxide bioavailability: a hypothesis to explain adverse effects of red blood cell transfusion.

Authors:  John D Roback; Robert B Neuman; Arshed Quyyumi; Roy Sutliff
Journal:  Transfusion       Date:  2011-04       Impact factor: 3.157

6.  Aggressive red blood cell transfusion: no association with improved outcomes for victims of isolated traumatic brain injury.

Authors:  Mark E George; David E Skarda; Charles R Watts; Hoai D Pham; Greg J Beilman
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

Review 7.  Red blood cell transfusion in the neurological ICU.

Authors:  Monisha A Kumar
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

8.  Risk associated with perioperative red blood cell transfusion in cranial surgery.

Authors:  Jonathan A Cohen; Nima Alan; Andreea Seicean; Robert J Weil
Journal:  Neurosurg Rev       Date:  2017-02-03       Impact factor: 3.042

9.  Factors associated with the development of anemia after subarachnoid hemorrhage.

Authors:  Tomoko R Sampson; Rajat Dhar; Michael N Diringer
Journal:  Neurocrit Care       Date:  2009-09-24       Impact factor: 3.210

10.  Red blood cell transfusion increases the risk of thrombotic events in patients with subarachnoid hemorrhage.

Authors:  Monisha A Kumar; Torrey A Boland; Mohamed Baiou; Michael Moussouttas; Jay H Herman; Rodney D Bell; Robert H Rosenwasser; Scott E Kasner; Valerie E Dechant
Journal:  Neurocrit Care       Date:  2014-02       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.